Market Cap : 229.16 B | Enterprise Value : 246.82 B | PE Ratio : 13.86 | PB Ratio : 5.30 |
---|
NYSE:MRK has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NYSE:MRK has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2022-08-12), Merck's share price is $90.5714. Merck's Book Value per Share for the quarter that ended in Jun. 2022 was $17.07. Hence, Merck's PB Ratio of today is 5.31.
Good Sign:
Merck & Co Inc stock PB Ratio (=5.21) is close to 3-year low of 4.81
The historical rank and industry rank for Merck's PB Ratio or its related term are showing as below:
During the past 13 years, Merck's highest PB Ratio was 8.56. The lowest was 1.64. And the median was 4.06.
MRK's PB Ratio is ranked worse thanDuring the past 12 months, Merck's average Book Value Per Share Growth Rate was 29.90% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 13.60% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -1.60% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -5.20% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Merck was 34.30% per year. The lowest was -13.80% per year. And the median was 4.80% per year.
The historical data trend for Merck's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Merck's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Merck's PB Ratio distribution charts can be found below:
* The bar in red indicates where Merck's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Merck's PB Ratio for today is calculated as follows:
PB Ratio | = | Share Price | / | Book Value per Share (Q: Jun. 2022) |
= | 90.5714 | / | 17.07 | |
= | 5.31 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
PB Ratio | = | Market Cap | / | (Total Stockholders Equity | - | Preferred Stock) |
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Thank you for viewing the detailed overview of Merck's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Baker Douglas M Jr | director | 370 WBASHA ST NORTH ST PAUL MN 55102 |
Oosthuizen Johannes Jacobus | officer: SVP, U.S. Market | 2000 GALLOPING HILL RD KENILWORTH NJ 07033 |
Garay Arpa | officer: SVP Human Health Global Mktg. | 2000 GALLOPING HILL RD KENILWORTH NJ 07033 |
Downing Cristal N | officer: Chief Comm. & Public Afrs Ofcr | 2000 GALLOPING HILL RD KENILWORTH NJ 07033 |
Klobuchar Michael A | officer: EVP - Chief Strategy Officer | 2000 GALLOPING HILL RD KENILWORTH NJ 07033 |
Lecointe-cephas Lisa | officer: SVP Chief Ethics & Com Officer | 2000 GALLOPING HILL RD KENILWORTH NJ 07033 |
Litchfield Caroline | officer: EVP & CFO | 2000 GALLOPING HILL RD KENILWORTH NJ 07033 |
Mayo Stephen | director | 2000 GALLOPING HILL RD KENILWORTH NJ 07033 |
Li Dean Y | officer: Executive VP & President, MRL | 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 |
Williams David Michael | officer: EVP,Chief Info&Digital Officer | MERCK & CO., INC. 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 |
Lavizzo-mourey Risa J | director | GENERAL ELECTRIC COMPANY 5 NECCO STREET BOSTON MA 02210 |
Seidman Christine E | director | MERCK & CO., INC. 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 |
Warden Kathy J | director | 2980 FAIRVIEW PARK DRIVE FALLS CHURCH VA 22042 |
Craig Pamela | director | C/O ACCENTURE 161 N CLARK STREET CHICAGO IL 60601 |
Brun Leslie A | director | 435 DEVON PARK DRIVE 700 BUILDING WAYNE PA 19087 |
From GuruFocus
Other Sources
By Zacks 2022-03-31
By Zacks 2022-03-28
By Zacks 2022-03-29
By Zacks 2022-03-25
By Zacks 2022-03-25
By Zacks 2022-04-04
By Zacks 2022-03-28
By Zacks 2022-03-29
By Zacks 2022-03-22
By Zacks 2022-04-05
By Zacks 2022-03-25
By Zacks 2022-03-29
By Zacks 2022-03-23
By Zacks 2022-03-17